Navigation Links
Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease
Date:2/16/2009

LOS ANGELES, Feb. 16 /PRNewswire/ -- Scientists announced today the publication of a landmark peer-reviewed paper in the February issue of the Bentham Open Stem Cell Journal which outlines the long term results of the world's first clinical trial using autologous neural stem cells for the treatment of Parkinson's disease. According to lead author, Michel F. Levesque, MD, FRCS(C), FACS, "We have documented the first successful adult neural stem cell transplantation to reverse the effects of Parkinson's disease and demonstrated the long term safety and therapeutic effects of this approach." Dr Levesque is a principal investigator for NeuroGeneration, a biotechnology company, and is affiliated with the UCLA School of Medicine and the Brain Research Institute.

The researcher reports that the publication of the article, "Therapeutic Microinjection of Autologous Adult Human Neural Stem Cells and Differentiated Neurons for Parkinson's Disease: Five-Year Post-Operative Outcome" in the Bentham Open Stem Cell Journal heralds an important moment in regenerative and personalized medicine. "Our paper describes how we were able to isolate patient-derived neural stem cells, multiply them in vitro and ultimately differentiate them to produce mature neurons before they are reintroduced into the brain's basal ganglia. This is performed without the patient requiring immunosuppressants. Of particular note are the striking results this study yielded -- for the five years following the procedure the patient's motor scales improved by over 80% for at least 36 months. A word of caution must be added however, since this is a single case study, a larger clinical trial is needed to replicate these findings," says Levesque.

"We have been pioneering the use of neural stem cells for neurodegenerative disorders since 1998 and were the first research team to successfully use differentiated adult neural stem cells for the cellular rest
'/>"/>

SOURCE NeuroGeneration
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
2. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
6. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
7. Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
8. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
9. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
10. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
11. AAOMS Updates BRONJ Position Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... DIEGO , Feb. 9 ... developer and manufacturer of precision intravascular therapy guidance ... of coronary and peripheral vascular disease, announced today ... Catheter device line from Lumen Biomedical. Volcano became ... in May 2009 . This acquisition reinforces ...
(Date:2/9/2010)... Feb. 9 Glycemion Strategies, ... strategic initiatives for diabetic consumers and their professional ... Data Retrieval Program to benefit the 30,000 US ... diabetic clients they serve. ,, The ... is designed to provide real-time access to health ...
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
Breaking Medicine Technology:Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 1Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 2Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 3Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 4Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 5Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 6Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 7Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 1Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 2Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 3Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 4Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 5Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus 28R 29 in Head to Head DURATION 3 Study 4751 6FDA Approves Seasonal Flu Vaccine for 2009 2010 52150 1FDA Approves Seasonal Flu Vaccine for 2009 2010 52150 2FDA Approves Seasonal Flu Vaccine for 2009 2010 52150 3
(Date:2/9/2010)... the effect of vitamin D begins in the womb, ... Children born to mothers who drink lots of milk ... during pregnancy have a much lower risk of developing ... new study included 35,794 U.S. nurses whose mothers provided ... nurses were followed for 16 years, and 199 of ...
(Date:2/9/2010)... Feb. 9 The nation,s fourth ... (COPD), is now being measured by the Minnesota ... The program focuses on three major causes of ... triggered or made worse by environmental factors such ... asthma, heart attacks and COPD. ,, The ...
(Date:2/9/2010)... The following statement is ... M.D., President, American Medical Association: ,, (Logo: ... Medical Association is pleased to support First ... Let,s Move Campaign. As the nation,s largest ... address obesity and are committed to reenergizing ...
(Date:2/9/2010)... (Boston)- Researchers from Boston University,s Slone Epidemiology Center ... status and risk for type 2 diabetes in ... the online American Journal of Epidemiology , ... relationship between neighborhood socioeconomic status and incidence of ... cohort of African-American women. , Type 2 diabetes ...
(Date:2/9/2010)... Rhonda Roby , PhD, ... University of North Texas Center for Human Identification ... in recently identifying three murder victims of the Chilean ... The Chilean government contacted Roby in 2006 ... team of the victims, identification program for Patio 29. ...
Breaking Medicine News(10 mins):Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007 2Health News:Neighborhood socioeconomic status and diabetes 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3
... gene therapy, plastic surgeons have delivered cancer fighting proteins ... with a 79 percent reduction in tumor volume, according ... and Reconstructive Surgery, the official medical journal of the ... delivery technique, which has yet to be tested in ...
... May 8 Genomic Health,Inc. (Nasdaq: GHDX ) ... Chief Executive Officer, will present at the Bank of,America ... May 14,2008 at 3:20 p.m. Pacific Time., In ... will present at the 7th Annual JMP Securities Research ...
... researchers say , , THURSDAY, May 8 (HealthDay News) -- ... varies among patients, that growth tends to be faster ... may help in planning and evaluating screening programs, clinical ... Using a new mathematical model, the scientists were also ...
... Train-the-Trainer, summer program offers comprehensive interpreter ... ... Every day, language barriers,prevent professionals who work in healthcare ... In fact, the,guesswork associated with navigating around communication roadblocks often,becomes ...
... Colo., May 8 Regular daily activities can,expose us ... breathe as well as the,common body care and household ... each other when they,re combined in the body and,have ... illnesses,including cancer and internal organ damage, can result., ...
... CARLSBAD, Calif., May 8 Ortho Organizers, ... continuing education,programs, announces the release of their ... http://www.newscom.com/cgi-bin/prnh/20080508/LATH052 ), Ortho Organizers President ... fulfills a critical market demand with the ...
Other Medicine News:Health News:Skin flaps deliver cancer-fighting therapy, ASPS study reveals 2Health News:Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference 2Health News:Breast Cancer Tends to Grow Faster in Younger Women 2Health News:Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters 2Health News:Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters 3Health News:Natural Solutions May Issue Illustrates 'Cocktail Effect' of Everyday Toxins; Offers Tips to Reduce Toxic Load 2Health News:Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments 2
... MAGNETOM Trio with Tim™ (Total ... workflow, highest speed, and highest resolution ... up to 16, advanced applications can ... routine. MAGNETOM Trio with Tim is ...
... a set of features for handling business ... that allows staff to customize the system ... Medical Billing's electronic encounter forms, charges can ... care when used with Practice Partner Patient ...
... system is the Cambridge Heart ... (MTWA) testing platform which simplifies ... death risk stratification. This new ... it can be configured to ...
... For those who prefer the versatility that a ... consider the Volk g-2 trabeculum. It features the ... two opposing mirrors angled at 60 and 64 ... NF (no-flange/no-fluid) design. Volk recommends the "Flanged" model ...
Medicine Products: